Stephen Thomas
Direttore/Membro del Consiglio presso ELIEM THERAPEUTICS, INC.
Patrimonio netto: 738 779 $ in data 30/06/2024
Posizioni attive di Stephen Thomas
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ELIEM THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 27/06/2024 | - |
Storia della carriera di Stephen Thomas
Precedenti posizioni note di Stephen Thomas
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
ValenzaBio, Inc.
 ValenzaBio, Inc. BiotechnologyHealth Technology ValenzaBio, Inc. develops safe and effective treatment options for patients with autoimmune and inflammatory diseases. The company is headquartered in Bethesda, MD. | Direttore Tecnico/Scientifico/R&S | 01/02/2020 | 01/01/2023 |
Ichorion Therapeutics, Inc.
 Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ichorion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of treatments for rare diseases. It focuses on a pipeline of genetically-targeted therapies for inherited metabolic disorders known as Inborn Errors of Metabolism. The company was founded by Stephen Thomas on July 7, 2017 and is headquartered in New York, NY. | Direttore Tecnico/Scientifico/R&S | 07/07/2017 | 01/09/2018 |
| Fondatore | 07/07/2017 | 01/09/2018 |
Formazione di Stephen Thomas
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Director/Board Member | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ELIEM THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Ichorion Therapeutics, Inc.
Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ichorion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of treatments for rare diseases. It focuses on a pipeline of genetically-targeted therapies for inherited metabolic disorders known as Inborn Errors of Metabolism. The company was founded by Stephen Thomas on July 7, 2017 and is headquartered in New York, NY. | Health Technology |
ValenzaBio, Inc.
ValenzaBio, Inc. BiotechnologyHealth Technology ValenzaBio, Inc. develops safe and effective treatment options for patients with autoimmune and inflammatory diseases. The company is headquartered in Bethesda, MD. | Health Technology |
- Borsa valori
- Insiders
- Stephen Thomas
- Esperienza
